Safety Alert

#	Title	Type of news	Date
95	Safety Signal of Panitumumab and the Risk of Panniculitis	Signal	2021-04-05
94	Safety Signal of Teriparatide and the Risk of Shivering	Signal	2021-03-07
93	Safety Signal of Natalizumab and the Risk of Acute Coronary Syndrome	Signal	2021-03-07
92	Safety Signal of Imatinib and the Risk of Polyserositis	Signal	2021-03-02
91	Safety Signal of Donepezil and the Risk of QT prolongation	Signal	2021-02-25
90	The SFDA Advises to Avoid Using NSAIDs in Pregnancy at 20 Weeks or Later	Warning	2021-02-09
89	Safety Signal of Dolutegravir and the Risk of Hyperglycemia	Signal	2021-02-21
88	Safety Signal of Clopidogrel and the Risk of Hypertension	Signal	2021-02-21
87	Safety Signal of Agomelatine and the Risk of Hypertension	Signal	2021-02-17
86	Safety Signal of Indapamide and the Risk of Rhabdomyolysis	Signal	2021-01-21